Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.
Tricia Hui Chyi TayNagavalli SomasundaramCindy LimLay Poh KhooAllan Zhi Kai GohYuh Shan LeeXin LiuMiriam TaoRichard QuekMohamad FaridEileen PoonJason Y S ChanEsther W Y ChangValerie S W YangYeow Tee GohDaryl TanColin DiongNicholas F GrigoropoulosChandramouli NagarajanMichelle PoonSanjay de MelAnand JeyasekharanEsther H L ChanJoanne LeeYen Lin CheeSoon Thye LimTiffany TangPublished in: Cancer reports (Hoboken, N.J.) (2022)
In summary, ICE showed high ORR but poor PFS in relapsed/refractory PTCL and NKTL. ORR of ICE in the first line setting appears better than real-world CHOP data and warrants further study.